BAC
Bank of America Corporation
BAC has the edge over HBAN overall, supported by stronger fundamentals and stronger valuation.
HBAN
Huntington Bancshares Incorporated
HBAN offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
HBAN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
HBAN's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like HBAN.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over HBAN in the historical PE scenario, which offers more potential upside but is not a forecast.
HBAN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.3x | $11.20 | -29% |
| Forward | 9.5x | $15.73 | — |
| Fair | 12x | $14.97 | -4.9% |
| Current | 13x | $15.73 | — |
| Expensive | 17x | $19.98 | +27% |
Historical ranges are pointers, not guarantees.
HBAN's PE is in its fair range at 13x. If earnings grow as analysts expect, today's price would be 9.5x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
HBAN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for HBAN, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over HBAN on earnings, with more consistent year-over-year improvement.
HBAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.66 | +38% |
| Q3 2026 | $1.21 | -15% |
| Q2 2026 | $1.29 | -3.7% |
| Q1 2026 | $1.30 | 0% |
| Q4 2025 | $1.39 | +14% |
| Q3 2025 | $1.42 | +37% |
| Q2 2025 | $1.34 | +26% |
| Q1 2025 | $1.30 | +17% |
| Q4 2024 | $1.22 | -1.6% |
HBAN earned $1.21 per share over the past year, down 15% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
HBAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8B | +31% |
| Q2 2026 | $2.8B | +46% |
| Q1 2026 | $2.6B | +34% |
| Q4 2025 | $2.2B | +11% |
| Q3 2025 | $2.1B | +14% |
| Q2 2025 | $1.9B | +7.5% |
| Q1 2025 | $1.9B | +9.5% |
| Q4 2024 | $2B | +14% |
HBAN has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -3.8 points |
| Q2 2026 | 32% | -1.3 points |
| Q1 2026 | 25% | -9.1 points |
| Q4 2025 | 29% | -5.2 points |
| Q3 2025 | 36% | +1.9 points |
| Q2 2025 | 33% | +0.4 points |
| Q1 2025 | 34% | +4.9 points |
| Q4 2024 | 34% | +20 points |
HBAN has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
HBAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $683M | +53% |
| Q2 2026 | $1B | +105% |
| Q1 2026 | $400M | -13% |
| Q4 2025 | $810M | -44% |
| Q3 2025 | $446M | +$926M |
| Q2 2025 | $500M | +90% |
| Q1 2025 | $459M | +6.3% |
| Q4 2024 | $1.5B | +74% |
HBAN has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over HBAN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
HBAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -1.4M shares |
| 1 year | +38% | +566M shares |
| 3 years | +40% | +581M shares |
| 5 years | +82% | +922M shares |
| Available history | +94% | +991M shares |
HBAN has 2B diluted shares, up 38% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100M |
| Q2 2026 | $159M |
| Q1 2026 | $150M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | $150M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
HBAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.5x | High |
| Q2 2026 | 5.0x | High |
| Q1 2026 | 6.3x | High |
| Q4 2025 | 4.8x | High |
| Q3 2025 | 4.6x | High |
| Q2 2025 | 5.0x | High |
| Q1 2025 | 5.4x | High |
| Q4 2024 | 4.9x | High |
HBAN has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
HBAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 25.1 | Neutral |
HBAN's weekly RSI is 44 (neutral) and its Stochastic is 25 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over HBAN on valuation relative to its sector.
HBAN PE vs Financial Services Sector
| Metric | HBAN | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.2% below |
| PE % | 62 | 63 | 1 pt below |
HBAN is trading at 13x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
HBAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.5 | 1.3% above |
| 20 week MA | $16.6 | 5.2% below |
| 50 week MA | $16.8 | 6.1% below |
| 100 week MA | $16.4 | 4.2% below |
| 200 week MA | $14.7 | 7.2% above |
HBAN has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over HBAN on returns for 2026, with the stronger performance.
HBAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.1 | $12.4 | -18% |
| 2021 | $12.4 | $15.3 | +24% |
| 2022 | $15.3 | $14.1 | -7.9% |
| 2023 | $14.1 | $12.7 | -9.5% |
| 2024 | $12.7 | $16.4 | +29% |
| 2025 | $16.4 | $17.7 | +8.3% |
| 2026 YTD | $17.7 | $15.7 | -11% |
HBAN has finished lower in three of the last six years. It's down 11% so far in 2026.